MRNA vs MTUS · rev $145.0M vs P/E 279, rev $649.3M
Moderna Inc (MRNA) versus Metallus, Inc (MTUS) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Metallus, Inc (MTUS) is a steel company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported MTUS revenue for 2026-06-30 was $649.3M. Net income was $14.3M. MTUS currently screens at market cap $814.2M and trailing P/E 279.4.
MRNA currently screens at market cap $24.52B. MTUS currently screens at market cap $814.2M and trailing P/E 279.4.
Not investment advice. Open the MRNA and MTUS stock pages for the full models.
Not investment advice.